|
IL271720D0
|
|
Continuous monitoring of the perfusion of an organ or extremity
|
|
WO2020121299A1
|
|
Stress disorder training
|
|
WO2020100144A1
|
|
Resilience training
|
|
WO2020039433A1
|
|
Fecal processing device and methods
|
|
WO2019234749A1
|
|
Endotracheal tube cleaning device, system and method
|
|
WO2019171386A1
|
|
Compositions and methods for treating age-related macular degeneration
|
|
US2020408761A1
|
|
Methods of diagnosing and treating bladder cancer
|
|
CN111587254A
|
|
T-cells comprising anti-CD 38 and anti-CD 138 chimeric antigen receptors and uses thereof
|
|
EP3720882A1
|
|
T-cells comprising two different chimeric antigen receptors and uses thereof
|
|
US2020022895A1
|
|
Tissue expansion method
|
|
EP3652541A1
|
|
Combination of markers for diagnosing cancer
|
|
US2019329063A1
|
|
Method for modifying the therapeutic effects of drugs
|
|
WO2018092129A1
|
|
Tissue repair device and method
|
|
WO2018051343A1
|
|
Dynamic treatment regime (dtr) implementations
|
|
IL251949D0
|
|
Small organic molecules for use in the treatment neuroinflammatory disorders
|
|
EP3402396A2
|
|
Coronary sinus electrophysiology measurements device and methods
|
|
EP3384287A1
|
|
Improved cytometric assays
|
|
WO2017025963A1
|
|
Methods and pharmaceutical compositions for improving wound healing using cd24
|
|
EP3307341A1
|
|
Mechanical apparatus and method for isolating stromal vascular fraction
|
|
EP3297551A1
|
|
Targeting locations in the body by generating echogenic disturbances
|
